All Pharma articles – Page 42
-
News
New guidance on pharmaceutical needs assessments
NHS Employers has launched guidance for primary care trusts on how to develop pharmaceutical needs assessments in line with world class commissioning.
-
News
End of life drugs move raises budget concerns
The National Institute for Health and Clinical Excellence is to proceed with controversial plans to broaden access to drugs for the terminally ill in the face of serious concerns from health managers.
-
News
'Cartel' pharmaceutical company pays £1m settlement
A pharmaceutical company accused of “anti-competitive cartel conduct” is to pay more than £1m in an out of court settlement.'
-
News
End of life drugs set to put financial pressure on PCTs
PCTs could face significant financial pressures as a result of proposals to make more drugs available to patients at the end of life, the NHS Confederation is warning.
-
News
Comply with NICE or pay, Care Quality Commission tells trusts
Healthcare providers could be shut down for failing to comply with National Institute for Health and Clinical Excellence guidance under plans to make adherence a requirement of the Care Quality Commission's registration scheme.
-
HSJ Knowledge
Pharmacy's perfect prescription for community health
Local pharmacies are more than just a purveyor of pills. They have the potential to improve the health of communities if commissioners have the courage to invest in them
-
News
Pharmaceutical industry tactics could be blocking generic drugs
The European Commission has uncovered a 'tool box' of pharmaceutical company strategies that may be delaying availability of cheaper generic alternatives to costly patented medicines.
-
News
Sir Michael Rawlins may extend tenure at NICE
A special exemption to appointment rules has been granted to allow Sir Michael Rawlins to extend his tenure as chair of an expanded National Institute for Health and Clinical Excellence.
-
HSJ Knowledge
Improving health with NICE guidance, supported by NICE
Winner: Central and Eastern Cheshire PCT and Mid Cheshire PCTNICE guidelines were the starting point for a project that set out to reduce incidences of pressure ulcers across primary and secondary care
-
News
Government announces new drug pricing scheme
A new deal on drug pricing will see the cost of branded drugs cut and ensure the cost of medicines reflects their importance to patients, the government has claimed.
-
News
Media Watch: top-ups
Now that government policy on co-payments has become clearer, it's interesting to learn that MPs have been benefiting from 'top-ups' of their own.
-
Leader
NHS top-ups are no substitute for offering a death with dignity
The response to Mike Richards’ review of co-payments has been largely positive. The cancer czar had a tricky job to do, forced to navigate choppy ideological waters and land at a practical resolution.
-
News
How are NHS top-ups going to affect your services?
The announcement that patients may top up their NHS care with unapproved treatments means managers face overseeing segregation of patients and tough commissioning decisions. Helen Crump reports
-
News
NICE may change drug rules for end of life
The National Institute for Health and Clinical Excellence wants to apply different rules when deciding whether to recommend expensive drugs for terminally ill patients with rare conditions.
-
News
Pharmacy chain to offer cervical cancer vaccine
Ten branches of Boots in London have begun piloting a private cervical cancer vaccination service.
-
News
NHS top-ups policy to be unveiled today
Health secretary Alan Johnson is set to unveil the government's new policy on NHS top-ups and co-payments later today.The expected announcement to MPs follows a wide-ranging review of the issue conducted by national clinical director for cancer Mike Richards.
-
News
Conservatives promise to speed up drug access
The Conservative Party has announced plans for changes to drug access and the National Institute for Health and Clinical Excellence.
-
Comment
Hilary Thomas on NHS top-ups
I approach the subject of NHS top-ups with some trepidation. The issue is complex and there are no easy answers. Considering it from the cancer perspective, I will attempt to throw light into some dark corners of the debate.
-
Comment
Michael White on pharmaceutical price regulation
I am indebted to Fred Curzon, 7th Earl Howe and veteran Tory health spokesman in the Lords, for a little gem of a debate in the upper house the other evening. It was doubtless neglected because of the Yachtgate affair in Corfu and relative trivia like the global financial collapse.
-
Comment
Mark Goldman on a happy ending for NHS top-ups
Are you sitting comfortably? Then I will begin. Once upon a time there was an elusive apostrophe. He lived in the NHS and was always causing mischief with his friend 'patients'. Together they would hide from the managers and clinicians.